Bayer has started a phase 3 trial of its intrauterine contraceptive Mirena in an endometrial condition that can lead to ...

Long-serving FDA figure Richard Pazdur has filed papers to retire, shortly after being appointed to lead the agency's Center ...

Johnson & Johnson's Imaavy has become the first FcRn blocker to be approved in the EU as a treatment for both adolescent and ...

The drive to roll out AI comes after sweeping job losses at the FDA that resulted from the cost-cutting drive implemented by ...

In a new pharmaphorum podcast to kick off December - in which month we'll be bringing you an episode a day through the ...

Successful AI implementation ultimately depends on how well these technologies align with the realities of clinical practice.

That is the message from the latest annual report (PDF) on clinical trials from the Association of the British Pharmaceutical ...

DTC pharma is America’s newest care pathway. TrumpRx has exposed the vacuum surrounding it.

In the 104-patient, phase 3 trial, a daily oral dose of tinlarebant achieved the primary efficacy endpoint by demonstrating a ...

The five-year SURMOUNT-REAL UK trial, part of a collaboration signed last year between Lilly and the UK government, will ...

An agreement between the UK and the US will maintain tariffs on imports into the US at 0% but, as a quid pro quo, prices of ...

The EMA has started a review of a regimen based on Pfizer and Astellas' Padcev and MSD's Keytruda that has been described as ...